Oramed Pharmaceuticals Inc.
ORMPNASDAQHealthcare● Active
$3.71
+$0.07(+1.92%)
Market Cap$151835761
P/E Ratio—
52W High$5.01
52W Low$1.98
Oramed Pharmaceuticals Inc. (ORMP) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ORMP · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-08 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $125.89M | $141.93M | $162.05M | $155.72M | $94.14M |
| Net Receivables | $4.64M | $0.00M | $0.00M | $0.00M | $0.00M |
| Inventory | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Current Assets | $133.27M | $143.22M | $162.58M | $157.11M | $95.34M |
| PP&E Net | $1.34M | $1.11M | $1.57M | $1.81M | $0.93M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $230.86M | $155.28M | $220.55M | $161.64M | $128.00M |
| Liabilities | |||||
| Short-Term Debt | $0.00M | $0.00M | $51.01M | $0.25M | $0.13M |
| Accounts Payable | $0.44M | $0.79M | $0.55M | $2.17M | $2.61M |
| Total Current Liabilities | $19.09M | $5.68M | $53.21M | $5.75M | $6.68M |
| Long-Term Debt | $0.00M | $0.00M | $0.00M | $0.65M | $0.40M |
| Total Liabilities | $31.12M | $9.93M | $57.66M | $10.49M | $11.48M |
| Stockholders Equity | |||||
| Retained Earnings | ($123.44M) | ($176.62M) | ($157.56M) | ($163.08M) | ($114.85M) |
| Total Stockholders Equity | $199.74M | $146.26M | $163.82M | $151.81M | $115.77M |
| Total Liab & Equity(computed) | $230.86M | $156.20M | $221.48M | $162.30M | $127.25M |
| Debt Summary | |||||
| Total Debt | $0.82M | $0.37M | $51.62M | $0.89M | $0.53M |
| Net Debt | ($45.12M) | ($54.05M) | $42.57M | ($39.57M) | ($76.71M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Oramed Pharmaceuticals Inc. data
About Oramed Pharmaceuticals Inc. (ORMP) Balance Sheet
Oramed Pharmaceuticals Inc. (ORMP) balance sheet shows total assets of $0.23B with cash of $0.13B. Total liabilities are $0.03B, total debt $0.00B, and stockholders equity $0.20B.
Frequently asked questions
ORMP · 4 questionsOramed Pharmaceuticals Inc. has total debt of $0.00B with net debt of ($0.05B).
ORMP total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10